Perspectives on Selected Myasthenia Gravis Posters and Abstracts From the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

To participate in this activity, please:

Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting. In addition to describing the methods and results of four studies presented at the meeting, Dr. Silvestri provides his expert comments on the clinical implications of each study. 

This activity is also available as a podcast: You may listen here

Course Credit:

0.75 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2024-11-20
Closes: 2025-11-20

Target Audience:

This activity was developed for neurologists and other clinicians who provide care for patients with myasthenia gravis.

This activity is supported by an educational grant from Alexion Pharmaceuticals, Inc.

    Presenting Faculty

  • Nicholas J. Silvestri, MD  headshot

    Nicholas J. Silvestri, MD

    Professor of Neurology
    University at Buffalo Jacobs School of Medicine & Biomedical Sciences
    Buffalo, New York